7/23/2025 – Rakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening

7/15/2025 – Rakovina Therapeutics Granted DTC Eligibility to Expand U.S. Investor Access

7/10/2025 – Rakovina Therapeutics Highlights Strength of Scientific Advisory Board Driving Innovation in AI-Enabled Oncology Drug Development

6/30/2025 – Rakovina Therapeutics Highlights Strong H1 Progress and Unveils Strategic Priorities for H2 2025

6/25/2025 – Rakovina Therapeutics Announces Results from 2025 Annual General Meeting

5/15/2025 – Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation

4/30/2025 – Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update